VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
VBI Vaccines reports 2020 executive compensation
By ExecPay News
Published: April 26, 2021
VBI Vaccines reported fiscal year 2020 executive compensation information on April 26, 2021.
In 2020, three executives at VBI Vaccines received on average a compensation package of $1.6M, a 47% increase compared to previous year.
Average pay of disclosed executives at VBI Vaccines
Jeffrey R. Baxter, Chief Executive Officer, received $2.2M in total, which increased by 63% compared to 2019. 66% of Baxter's compensation, or $1.5M, was in option awards. Baxter also received $175K in bonus, $535K in salary, as well as $62K in other compensation.
Francisco Diaz-Mitoma, Chief Medical Officer, received a compensation package of $1.2M, which increased by 33% compared to previous year. 60% of the compensation package, or $732K, was in option awards.
David E. Anderson, Chief Scientific Officer, earned $1.2M in 2020, a 38% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2021.